The bill S. 749 proposes the establishment of the "Prescription Medicine Study Committee" in South Carolina, aimed at exploring innovative strategies to reduce the costs of essential prescription medications for residents. The committee will focus on medications critical for managing chronic diseases such as diabetes, heart disease, and dementia, which significantly impact the health and financial stability of South Carolinians. It will evaluate current cost barriers, review successful methods from other states and industries, and recommend policy changes or initiatives that could lower prescription costs while ensuring patient safety and care quality.

The committee will consist of various appointed members, including chairs from relevant legislative committees, directors from state health and insurance departments, and representatives from health plans and pharmacy benefits management companies. It is tasked with gathering input from consumers and stakeholders, and it will submit a report of its findings and recommendations to the General Assembly by December 31, 2026. The committee will dissolve after submitting its report unless reauthorized by a joint resolution.